• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对癌症免疫治疗中免疫相关不良事件遗传风险因素的表型研究进展

Phenotypic insights into genetic risk factors for immune-related adverse events in cancer immunotherapy.

机构信息

Department of Oncology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, China.

Guangdong Provincial Hospital of Chinese Medicine Postdoctoral Research Workstation, Guangzhou, Guangdong, China.

出版信息

Cancer Immunol Immunother. 2024 Nov 2;74(1):1. doi: 10.1007/s00262-024-03854-8.

DOI:10.1007/s00262-024-03854-8
PMID:39487892
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11531409/
Abstract

BACKGROUND

Immune-related adverse events (irAEs) pose substantial challenges in the realm of cancer immunotherapy, frequently affecting treatment efficacy and patient safety. To address the urgent need for identifying risk factors associated with irAEs, we conducted a comprehensive phenotype-wide Mendelian randomization analysis (MR-PheWAS).

METHODS

Utilizing publicly accessible genome-wide association study (GWAS) data, this investigation evaluated the impact of over 5000 exposure variables on susceptibility to irAEs using univariate Mendelian randomization (MR). We categorized these correlations and further explored potential mechanisms by which associated traits might influence irAEs through multivariate MR.

RESULTS

MR-PheWAS identified numerous risk factors for irAEs, encompassing both previously documented and novel associations. Specifically, we identified 105 traits with probable causal relationships to all-grade irAEs and 119 traits with suggestive associations. For high-grade irAEs, we categorized 122 traits as probably associated and 141 as suggestively associated. Notably, multivariate MR analyses uncovered intricate interactions, particularly highlighting how diabetes impacts all-grade irAEs through mediators such as body mass index and sex hormone-binding globulin.

CONCLUSIONS

This study has not only identified new risk factors for irAEs but also confirmed several well-established ones. Further investigation is crucial to validate and assess these identified risk factors within clinical trials. A mechanistic understanding of these causal factors is essential for improving the management and prevention of irAEs.

摘要

背景

免疫相关不良事件(irAEs)在癌症免疫治疗领域带来了巨大挑战,经常影响治疗效果和患者安全。为了解决确定 irAEs 相关风险因素的迫切需求,我们进行了全面的表型全基因组关联研究(MR-PheWAS)。

方法

利用公开的全基因组关联研究(GWAS)数据,本研究使用单变量 Mendelian 随机化(MR)评估了 5000 多个暴露变量对 irAEs 易感性的影响。我们对这些相关性进行了分类,并通过多变量 MR 进一步探讨了相关特征可能通过哪些潜在机制影响 irAEs。

结果

MR-PheWAS 确定了许多 irAEs 的风险因素,包括先前记录的和新的关联。具体来说,我们确定了 105 个与所有等级 irAEs 可能有因果关系的特征,以及 119 个有提示关联的特征。对于高级别 irAEs,我们将 122 个特征归类为可能相关,141 个特征归类为提示相关。值得注意的是,多变量 MR 分析揭示了复杂的相互作用,特别是突出了糖尿病如何通过身体质量指数和性激素结合球蛋白等介质影响所有等级 irAEs。

结论

本研究不仅确定了 irAEs 的新风险因素,还证实了一些已确立的风险因素。进一步的研究对于在临床试验中验证和评估这些已确定的风险因素至关重要。对这些因果因素的机制理解对于改善 irAEs 的管理和预防至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5d6/11531409/7f8e2b784886/262_2024_3854_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5d6/11531409/f83f8254c1fb/262_2024_3854_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5d6/11531409/6039ddc161ba/262_2024_3854_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5d6/11531409/df6e7a6817d9/262_2024_3854_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5d6/11531409/6cfa0ae8a6d5/262_2024_3854_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5d6/11531409/dfee7379e7d7/262_2024_3854_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5d6/11531409/7f8e2b784886/262_2024_3854_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5d6/11531409/f83f8254c1fb/262_2024_3854_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5d6/11531409/6039ddc161ba/262_2024_3854_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5d6/11531409/df6e7a6817d9/262_2024_3854_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5d6/11531409/6cfa0ae8a6d5/262_2024_3854_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5d6/11531409/dfee7379e7d7/262_2024_3854_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5d6/11531409/7f8e2b784886/262_2024_3854_Fig6_HTML.jpg

相似文献

1
Phenotypic insights into genetic risk factors for immune-related adverse events in cancer immunotherapy.对癌症免疫治疗中免疫相关不良事件遗传风险因素的表型研究进展
Cancer Immunol Immunother. 2024 Nov 2;74(1):1. doi: 10.1007/s00262-024-03854-8.
2
Univariable and multivariable Mendelian randomization study identified the key role of gut microbiota in immunotherapeutic toxicity.单变量和多变量孟德尔随机化研究确定了肠道微生物群在免疫治疗毒性中的关键作用。
Eur J Med Res. 2024 Mar 12;29(1):161. doi: 10.1186/s40001-024-01741-7.
3
Exploring new drug treatment targets for immune related bone diseases using a multi omics joint analysis strategy.使用多组学联合分析策略探索免疫相关骨疾病的新药治疗靶点。
Sci Rep. 2025 Mar 27;15(1):10618. doi: 10.1038/s41598-025-94053-7.
4
Exploring risk factors for endocrine-related immune-related adverse events: Insights from meta-analysis and Mendelian randomization.探讨内分泌相关免疫相关不良事件的风险因素:来自荟萃分析和孟德尔随机化的见解。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2410557. doi: 10.1080/21645515.2024.2410557. Epub 2024 Oct 8.
5
Placebo immune-related adverse events (irAEs): A neglected phenomenon in cancer immunotherapy trials.安慰剂免疫相关不良事件(irAEs):癌症免疫治疗试验中被忽视的现象。
Eur J Cancer. 2024 Sep;208:114203. doi: 10.1016/j.ejca.2024.114203. Epub 2024 Jul 5.
6
The immune factors have complex causal regulation effects on kidney stone disease: a mendelian randomization study.免疫因素对肾结石病有复杂的因果调节作用:一项孟德尔随机化研究。
BMC Immunol. 2024 Jun 14;25(1):34. doi: 10.1186/s12865-024-00627-x.
7
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients.免疫相关不良反应谱与 NSCLC 患者抗 PD1 免疫治疗疗效的相关性。
Clin Lung Cancer. 2019 Jul;20(4):237-247.e1. doi: 10.1016/j.cllc.2019.02.006. Epub 2019 Feb 21.
8
Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events.另一角度看待癌症患者 BMI 与程序性死亡蛋白-1(PD-1)/程序性死亡配体 1(PD-L1)检查点抑制剂临床获益的相关性:免疫相关不良事件的多中心分析。
Eur J Cancer. 2020 Mar;128:17-26. doi: 10.1016/j.ejca.2019.12.031. Epub 2020 Mar 5.
9
Blood Pressure, Cardiometabolic Traits, and Cardiovascular Events in Women With Uterine Fibroids: A Genetic Correlation and Mendelian Randomization Study.子宫肌瘤女性的血压、心脏代谢特征与心血管事件:一项遗传相关性和孟德尔随机化研究
J Am Heart Assoc. 2025 Apr 15;14(8):e036697. doi: 10.1161/JAHA.124.036697. Epub 2025 Apr 10.
10
Exploring Potential Drug Targets in Multiple Cardiovascular Diseases: A Study Based on Proteome-Wide Mendelian Randomization and Colocalization Analysis.探索多种心血管疾病中的潜在药物靶点:一项基于全蛋白质组孟德尔随机化和共定位分析的研究
Cardiovasc Ther. 2025 Feb 21;2025:5711316. doi: 10.1155/cdr/5711316. eCollection 2025.

引用本文的文献

1
Rhinosinusitis as an Immune-Related Adverse Event: Clinical Characteristics, Management, and Prognostic Implications in Metastatic Melanoma Patients.鼻窦炎作为一种免疫相关不良事件:转移性黑色素瘤患者的临床特征、管理及预后意义
Cancers (Basel). 2025 Jul 10;17(14):2297. doi: 10.3390/cancers17142297.
2
Bibliometric and visualized analysis of global distribution and research frontiers in tumor immune escape.肿瘤免疫逃逸全球分布与研究前沿的文献计量学及可视化分析
Front Immunol. 2025 Jun 5;16:1586120. doi: 10.3389/fimmu.2025.1586120. eCollection 2025.

本文引用的文献

1
Immune-related adverse events in non-small cell lung cancer: Occurrence, mechanisms and therapeutic strategies.非小细胞肺癌的免疫相关不良反应:发生机制与治疗策略。
Clin Transl Med. 2024 Mar;14(3):e1613. doi: 10.1002/ctm2.1613.
2
Gut microbial structural variation associates with immune checkpoint inhibitor response.肠道微生物结构的变化与免疫检查点抑制剂的反应有关。
Nat Commun. 2023 Nov 16;14(1):7421. doi: 10.1038/s41467-023-42997-7.
3
Mendelian randomization.孟德尔随机化
Nat Rev Methods Primers. 2022 Feb 10;2. doi: 10.1038/s43586-021-00092-5.
4
Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer.癌症中检查点阻断治疗免疫相关不良反应的风险因素的综合分析。
Nat Cancer. 2023 Jun;4(6):844-859. doi: 10.1038/s43018-023-00572-5. Epub 2023 Jun 12.
5
Psychiatric disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database.与免疫检查点抑制剂相关的精神障碍:对美国食品药品监督管理局不良事件报告系统(FAERS)数据库的药物警戒分析
EClinicalMedicine. 2023 Apr 21;59:101967. doi: 10.1016/j.eclinm.2023.101967. eCollection 2023 May.
6
Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology.癌症免疫治疗学会(SITC)免疫检查点抑制剂相关免疫相关不良事件(irAEs)术语的共识定义。
J Immunother Cancer. 2023 Mar;11(3). doi: 10.1136/jitc-2022-006398.
7
Germline variants associated with toxicity to immune checkpoint blockade.与免疫检查点阻断毒性相关的种系变异。
Nat Med. 2022 Dec;28(12):2584-2591. doi: 10.1038/s41591-022-02094-6. Epub 2022 Dec 16.
8
A review of Mendelian randomization in amyotrophic lateral sclerosis.肌萎缩侧索硬化症中的孟德尔随机化研究综述。
Brain. 2022 Apr 29;145(3):832-842. doi: 10.1093/brain/awab420.
9
Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration.加强流行病学中基于孟德尔随机化的观察性研究报告 (STROBE-MR): 解释和详述。
BMJ. 2021 Oct 26;375:n2233. doi: 10.1136/bmj.n2233.
10
Gut Microbiota May Mediate AEs.肠道微生物群可能介导不良事件。
Cancer Discov. 2021 Sep;11(9):2118. doi: 10.1158/2159-8290.CD-NB2021-0371. Epub 2021 Aug 9.